The Road to Psychedelics Legalization
Matthew X. Lowe, Ph.D., the Research Director of Unlimited Sciences, explains why observational research is the key for eventual legalization of psychedelic drugs.
Matthew X. Lowe, Ph.D., the Research Director of Unlimited Sciences, explains why observational research is the key for eventual legalization of psychedelic drugs.
“Considering all our advocacy on this issue, this employee benefit is the next logical step,” says company president Michael Bronner.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.